Green Alpha Advisors, LLC Exact Sciences Corp Transaction History

Green Alpha Advisors, LLC

$112 Million
Q4 2024

A detailed history of Green Alpha Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 3,618 shares of EXAS stock, worth $178,403. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,618

Previous 4,064 10.97%

Holding current value

$178,403

Previous $276,000 26.45%

% of portfolio

0.18%

Previous 0.22%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$49.33 - $71.97 $22,001 - $32,098	-446 Reduced 10.97%	3,618 $203,000
Q3 2024 Oct 07, 2024	BUY	$42.43 - $70.83 $172,435 - $287,853	4,064 New	4,064 $276,000
Q1 2024 Apr 09, 2024	BUY	$56.27 - $73.77 $1,181 - $1,549	21 Added 0.47%	4,469 $308,000
Q4 2023 Jan 04, 2024	SELL	$59.06 - $75.72 $26,281 - $33,695	-445 Reduced 9.09%	4,448 $329,000
Q3 2023 Oct 10, 2023	BUY	$65.94 - $99.04 $10,880 - $16,341	165 Added 3.49%	4,893 $333,000
Q2 2023 Jul 06, 2023	SELL	$62.68 - $95.05 $27,579 - $41,822	-440 Reduced 8.51%	4,728 $443,000
Q1 2023 Apr 06, 2023	SELL	$47.19 - $70.77 $9,626 - $14,437	-204 Reduced 3.8%	5,168 $350,000
Q4 2022 Jan 12, 2023	BUY	$30.35 - $53.15 $163,040 - $285,521	5,372 New	5,372 $0
Q2 2022 Jul 08, 2022	BUY	$35.61 - $76.23 $10,932 - $23,402	307 Added 6.05%	5,383 $212,000
Q1 2022 Apr 19, 2022	BUY	$57.56 - $82.54 $27,686 - $39,701	481 Added 10.47%	5,076 $355,000
Q4 2021 Jan 12, 2022	SELL	$72.5 - $100.68 $33,567 - $46,614	-463 Reduced 9.15%	4,595 $358,000
Q3 2021 Oct 12, 2021	BUY	$90.24 - $124.05 $63,348 - $87,083	702 Added 16.12%	5,058 $483,000
Q2 2021 Jul 22, 2021	BUY	$93.66 - $139.27 $155,381 - $231,048	1,659 Added 61.51%	4,356 $541,000
Q1 2021 Jul 22, 2021	BUY	$116.57 - $155.01 $314,389 - $418,061	2,697 New	2,697 $355,000

Others Institutions Holding EXAS

# of Institutions

683

Shares Held

163M

Call Options Held

3.42M

Put Options Held

2.34M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.

Account

Green Alpha Advisors, LLC Exact Sciences Corp Transaction History